Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia

Although tyrosine kinase inhibitors (TKIs) have significantly improved the prognosis of chronic myeloid leukemia (CML), the ability of TKIs to eradicate CML remains uncertain and patients must continue TKI therapy for indefinite periods. In this study, we performed whole-exome sequencing to identify...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Blood Cancer J
मुख्य लेखकों: Togasaki, E, Takeda, J, Yoshida, K, Shiozawa, Y, Takeuchi, M, Oshima, M, Saraya, A, Iwama, A, Yokote, K, Sakaida, E, Hirase, C, Takeshita, A, Imai, K, Okumura, H, Morishita, Y, Usui, N, Takahashi, N, Fujisawa, S, Shiraishi, Y, Chiba, K, Tanaka, H, Kiyoi, H, Ohnishi, K, Ohtake, S, Asou, N, Kobayashi, Y, Miyazaki, Y, Miyano, S, Ogawa, S, Matsumura, I, Nakaseko, C, Naoe, T
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Nature Publishing Group 2017
विषय:
Original Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5436079/
https://ncbi.nlm.nih.gov/pubmed/28452984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2017.36
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन